Young children show immune sensitization to tuberculosis

Tuberculosis in very young children presents both medical and diagnostic challenges, and questions about how to detect infection remain controversial. In a study led by corresponding author Christina Lancioni, researchers set out to measure immune sensitization to Mycobacterium tuberculosis among children under five years of age, comparing those who had tuberculosis disease with those who did not. The team used commonly used immune tests and statistical approaches to look for differences between groups and to estimate how test results related to the odds of having TB. Specifically, they compared test results in simple univariate analyses, then used a logistic regression model to estimate adjusted odds of TB linked to positive test findings. They also tested whether patterns held when children were split into two age bands (< 2 years vs. 2-5 years) in a sensitivity analysis. Finally, the study compared results from two components of a blood-based interferon-gamma test, the QFT-Plus' TB tube 1 and TB tube 2, to see how well those two measurements agreed with one another.

The study examined markers of immune-sensitization and found that sensitization was present, with the effect most pronounced in children who had TB disease. In statistical comparisons, a positive TST was associated with higher odds of TB: the adjusted odds ratio was 2.09 with a 95% confidence interval of 1.02 to 4.37, meaning the odds of TB were about two times higher among children with a positive TST in this analysis. The investigators reported that the QFT-Plus' TB tube 1 and TB tube 2 results were highly correlated, indicating strong concordance between those two parts of the QFT-Plus test. The team’s approach included univariate analysis to highlight group differences, a logistic regression model to estimate the relationship between test positivity and TB, and a sensitivity analysis stratified by age (< 2 years vs. 2-5 years) to examine whether findings varied with age.

These findings suggest that immune tests can detect sensitization to Mycobacterium tuberculosis in young children and that certain test results are associated with higher odds of active TB disease. The two-part QFT-Plus blood test showed consistent results across its TB tube 1 and TB tube 2 components, supporting the internal agreement of that assay in this age group. The association between a positive TST and roughly doubled odds of TB highlights the potential role of traditional skin testing in identifying children who may need closer evaluation, though the observational design limits conclusions about cause and effect. Stratifying by age was part of the sensitivity work the team did, acknowledging that immune responses can differ in infants and toddlers. Overall, the study provides data that can inform clinicians and public health teams who weigh test results when deciding which young children require further investigation or treatment for tuberculosis.